Danny Irawan
Department of Internal Medicine, Faculty of Medicine, Universitas Nahdlatul Ulama Surabaya

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

The Effect of Vitamin-D Supplementation on HDAC2 Levels in Stable COPD Patients Adyan Donastin; Danny Irawan; Effendy; Rifky Dwi Aditya Iryawan; Nuzlan Nuari; Betta Mega Oktaviana; Devy Yahya; Akbar Reza Muhammad
Jurnal Ilmiah Kesehatan Vol 19 No 03 (2026): Jurnal Ilmiah Kesehatan (Journal of Health Science) 
Publisher : Universitas Nahdlatul Ulama Surabaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33086/jhs.v19i03.7169

Abstract

Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of global mortality, with persistent lung inflammation contributing to its progression. This inflammation is partially due to reduced levels of the Histone deacetylase 2 (HDAC2) protein. Research shows that Vitamin D can modulate HDAC2 levels and slow the advancement of COPD. This experimental study aimed to evaluate the effect of vitamin D supplementation on HDAC2 expression in stable COPD patients at Jemursari Islamic Hospital. Five randomly selected COPD patients received a daily dosage of 5000 IU of Vitamin D for three months. Serum levels of 25(OH) D and HDAC2 were measured before and after the intervention. The results showed a significant increase in both Vitamin D and HDAC2 levels, with a notable, though not statistically significant, improvement in lung function. The findings suggest that consistent Vitamin D supplementation can reduce inflammation by raising HDAC2 levels, potentially slowing lung damage in COPD patients. Therefore, Vitamin D treatment is beneficial in managing COPD by improving lung health and preventing disease progression.